跳至主要内容
临床试验/JPRN-jRCT1062220115
JPRN-jRCT1062220115招募中3 期

Randomised clinical trial to investigate the Efficacy of CPAP for Mild cognitive Impairment with Obstructive Sleep Apnoea - MORE

Fujii Masanori0 个研究点目标入组 130 人开始时间: 2023年3月31日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 50age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Aged 50 years and over
  • 2) AHI over 20 on polysomnography or AHI over 40 on brief monitoring with a confirmed diagnosis of OSAS
  • 3) Patients with a clinical diagnosis of MCI based on DSM-5 (Diagnostic & Statistical Manual of Mental Disorders,5th edition) or NIA-AA (National Institute on Aging-Alzheimer Association Joint Working Group) diagnostic criteria.
  • 4) Cases in which the attending physician is able to judge that CPAP treatment is possible, and cases in which the patient lives with or has a family member who can support the patient as a study partner throughout the course of treatment (at least 3 times a week face to face or telephone contact is possible).
  • 5) After receiving a full explanation of the study, select patients who have been fully informed about their participation in the study, and who have given their written consent, either by themselves or by a proxy, with full understanding.

排除标准

  • 1) A respiratory event index of 60 or more on an out of center sleep testing or an apnoea-hypopnoea index of 60 or more on a Polysomnography
  • 2) Psychiatric disorders such as depression and schizophrenia
  • 3) Delirium
  • 4) Parkinson's disease
  • 5) Medical conditions affecting cognitive function (hypothyroidism, parathyroid disorders, vitamin B12 and folic acid deficiency, neurosyphilis, neuro-Beichet's disease and other collagen diseases, severe diabetes, chronic liver disorders, chronic respiratory diseases, hypoglycaemia, etc.)
  • 6) Epilepsy
  • 7) Neurosurgical diseases (e.g. brain tumours, chronic subdural haematomas, normal hydrocephalus) and massive stroke cases
  • 8) Cases of new prescriptions or volume changes of dementia drugs in the last 3 months
  • 9) Cases with a history of excessive alcohol consumption or alcohol dependence
  • 10) Patients with severe visual or hearing impairment that interferes with daily life.

研究者

发起方
Fujii Masanori

相似试验

MCI patients with OSAS Randomised clinical trial to... | 临床试验